{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:49:51Z","timestamp":1793364591137,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T00:00:00Z","timestamp":1507680000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00520-017-3915-1","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T04:22:01Z","timestamp":1507695721000},"page":"947-955","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Defibrotide for the treatment of sinusoidal obstruction syndrome: evaluation of response to therapy and patient outcomes"],"prefix":"10.1007","volume":"26","author":[{"given":"John","family":"Coutsouvelis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Kirkpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,11]]},"reference":[{"issue":"4","key":"3915_CR1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/bjh.13215","volume":"168","author":"E Carreras","year":"2015","unstructured":"Carreras E (2015) How I manage sinusoidal obstruction syndrome after haemopoietic cell transplantation. Br J Haematol 168(4):481\u2013491","journal-title":"Br J Haematol"},{"issue":"4","key":"3915_CR2","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/bjh.12558","volume":"163","author":"FL Dignan","year":"2013","unstructured":"Dignan FL, Wynn RF, Hadzic N, Karani J, Quaglia A, Pagliuca A et al (2013) BCSH\/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haemopoietic stem cell transplantation. Br J Haematol 163(4):444\u2013457","journal-title":"Br J Haematol"},{"issue":"29","key":"3915_CR3","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.3748\/wjg.v13.i29.3918","volume":"13","author":"M Senzolo","year":"2007","unstructured":"Senzolo M, Germani G, Cholongitas E, Burra P, Burroughs AK (2007) Veno occlusive disease: update on clinical management. World J Gastroenterol 13(29):3918\u20133924","journal-title":"World J Gastroenterol"},{"issue":"6","key":"3915_CR4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/bmt.2015.52","volume":"50","author":"M Mohty","year":"2015","unstructured":"Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M et al (2015) Sinusoidal obstruction syndrome\/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 50(6):781\u2013789","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"3915_CR5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","volume":"16","author":"JA Coppell","year":"2010","unstructured":"Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A et al (2010) Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant 16(2):157\u2013168","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"3915_CR6","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/bmt.2016.130","volume":"51","author":"M Mohty","year":"2016","unstructured":"Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M et al (2016) Revised diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant 51(7):906\u2013912","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"3915_CR7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.bmt.1705899","volume":"41","author":"VT Ho","year":"2008","unstructured":"Ho VT, Revta C, Richardson PG (2008) Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies. Bone Marrow Transplant 41(3):229\u2013237","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"3915_CR8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","volume":"4","author":"GB McDonald","year":"1984","unstructured":"McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED (1984) Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 4(1):116\u2013122","journal-title":"Hepatology"},{"issue":"3","key":"3915_CR9","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbmt.2015.09.024","volume":"22","author":"JH Dalle","year":"2016","unstructured":"Dalle JH, Giralt SA (2016) Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: risk factors and stratification, prophylaxis, and treatment. Biol Blood Marrow Transplant 22(3):400\u2013409","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"3915_CR10","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG et al (1987) Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 44(6):778\u2013783","journal-title":"Transplantation"},{"issue":"3","key":"3915_CR11","first-page":"197","volume":"10","author":"HM Shulman","year":"1992","unstructured":"Shulman HM, Hinterberger W (1992) Hepatic veno-occlusive disease\u2014liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transplant 10(3):197\u2013214","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"3915_CR12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bbmt.2010.11.019","volume":"17","author":"M Palomo","year":"2011","unstructured":"Palomo M, Diaz-Ricart M, Rovira M, Escolar G, Carreras E (2011) Defibrotide prevents the activation of macrovascular and microvascular endothelia caused by soluble factors released to blood by autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 17(4):497\u2013506","journal-title":"Biol Blood Marrow Transplant."},{"issue":"1\u20132","key":"3915_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2013.05.001","volume":"59","author":"R Pescador","year":"2013","unstructured":"Pescador R, Capuzzi L, Mantovani M, Fulgenzi A, Ferrero ME (2013) Defibrotide: properties and clinical use of an old\/new drug. Vasc Pharmacol 59(1\u20132):1\u201310","journal-title":"Vasc Pharmacol"},{"issue":"13","key":"3915_CR14","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1182\/blood-2015-10-676924","volume":"127","author":"P Richardson","year":"2016","unstructured":"Richardson P, Riches ML, Keman NA, Brochstein J, Mineishi S, Termuhlen AM et al (2016) Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood 127(13):1656\u20131665","journal-title":"Blood"},{"issue":"1","key":"3915_CR15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1517\/14740338.2012.749855","volume":"12","author":"PG Richardson","year":"2013","unstructured":"Richardson PG, Corbacioglu S, Ho VT-V, Kernan NA, Lehmann LE, Maguire C et al (2013) Drug safety evaluation of defibrotide. Expert Opin Drug Saf 12(1):123\u2013136","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"3915_CR16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1586\/ehm.12.18","volume":"5","author":"S Corbacioglu","year":"2012","unstructured":"Corbacioglu S, Kernan NA, Lehmann LE, Brochstein J, Revta C, Grupp SA et al (2012) Defibrotide for the treatment of heaptic veno-occlusive disease in children after hematopoietic stem cell transplantation. Expert Rev Haematol 5(3):291\u2013302","journal-title":"Expert Rev Haematol"},{"issue":"1","key":"3915_CR17","first-page":"3","volume":"50","author":"K Yakushijin","year":"2009","unstructured":"Yakushijin K, Okamura A, Ono K, Kawano Y, Kawano H, Funakoshi Y et al (2009) Defibrotide therapy for patients with sinusoidal obstruction syndrome after hematopoietic stem cell transplantation. Rinsho Ketsueki Jpn J Clin Hematol 50(1):3\u20138","journal-title":"Rinsho Ketsueki Jpn J Clin Hematol"},{"issue":"4","key":"3915_CR18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/ehm.09.30","volume":"2","author":"P Richardson","year":"2009","unstructured":"Richardson P, Linden E, Revta C, Ho VT-V (2009) Use of defibrotide in the treatment and prevention of veno-occlusive disease. Expert Review Haematology 2(4):365\u2013376","journal-title":"Expert Review Haematology"},{"key":"3915_CR19","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1046\/j.1365-2141.2000.02475.x","volume":"111","author":"R Chopra","year":"2000","unstructured":"Chopra R, Eaton JD, Grassi A, Potter M, Shaw B, Salat C et al (2000) Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study. Br J Haematol 111:1122\u20131129","journal-title":"Br J Haematol"},{"issue":"9","key":"3915_CR20","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1200\/JCO.1993.11.9.1729","volume":"11","author":"SI Bearman","year":"1993","unstructured":"Bearman SI, Anderson GL, Mori M, Hinds MS, Shulman HM, McDonald GB (1993) Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol 11(9):1729\u20131736","journal-title":"J Clin Oncol"},{"issue":"5","key":"3915_CR21","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.transproceed.2007.01.075","volume":"39","author":"GT Sucak","year":"2007","unstructured":"Sucak GT, Aki ZS, Yagci M, Yegin ZA, Ozkurt ZN, Haznedar R (2007) Treatment of sinusoidal obstruction syndrome with defibrotide: a single-center experience. Transplant Proc 39(5):1558\u20131563","journal-title":"Transplant Proc"},{"issue":"2","key":"3915_CR22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.bmt.1704329","volume":"33","author":"S Corbacioglu","year":"2004","unstructured":"Corbacioglu S, Greil J, Peters C, Wulffraat N, Laws HJ, Dilloo D et al (2004) Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplant 33(2):189\u2013195","journal-title":"Bone Marrow Transplant"},{"issue":"13","key":"3915_CR23","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","volume":"100","author":"PG Richardson","year":"2002","unstructured":"Richardson PG, Murakami C, Jin Z, Warren D, Momtaz P, Hoppensteadt D et al (2002) Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. Blood 100(13):4337\u20134343","journal-title":"Blood"},{"issue":"7","key":"3915_CR24","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/pbc.20934","volume":"48","author":"SR Bulley","year":"2007","unstructured":"Bulley SR, Strahm B, Doyle J, Dupuis LL (2007) Defibrotide for the treatment of hepatic veno-occlusive disease in children. Pediatr Blood Cancer 48(7):700\u2013704","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"3915_CR25","first-page":"726B","volume":"91","author":"DA Tsakiras","year":"2006","unstructured":"Tsakiras DA (2006) Prophylaxis and treatment of hepatic veno-occlusive disease after pediatric stem cell transplantation. Haematologica 91(6):726B","journal-title":"Haematologica"},{"issue":"4","key":"3915_CR26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1399-0012.2012.01604.x","volume":"26","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang Y, Huang H (2012) Defibrotide for the prevention of hepatic veno-occlusive disease after hematopoietic stem cell transplantation: a systematic review. Clin Transpl 26(4):511\u2013519","journal-title":"Clin Transpl"},{"issue":"3","key":"3915_CR27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/14712598.2012.657623","volume":"12","author":"T Gugliemelli","year":"2012","unstructured":"Gugliemelli T, Bringhen S, Palumbo A (2012) Update on the use of defibrotide. Expert Opin Biol Ther 12(3):353\u2013361","journal-title":"Expert Opin Biol Ther"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-017-3915-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3915-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3915-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T03:20:09Z","timestamp":1516850409000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-017-3915-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,11]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["3915"],"URL":"https:\/\/doi.org\/10.1007\/s00520-017-3915-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,11]]}}}